Entering text into the input field will update the search result below

KindredBio announces positive results from KIND-014 for the treatment of gastric ulcers in horses

  • Kindred Biosciences (KIN) announces positive results from its pilot field study of KIND-014 for the treatment of gastric ulcers in horses.
  • This study was a placebo-controlled, dose-ranging study that enrolled 53 horses (40 horses in three groups with different doses and schedules, 13 in the placebo group). The objective was to determine the effective dose of KIND-014.
  • At Week 3, the gastric ulcer resolution (gastric ulcer score=0) rates in all three KIND-014 groups were statistically higher than the placebo group (p-values < 0.05).

Recommended For You

More Trending News

About ELAN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ELAN--
Elanco Animal Health Incorporated